The mRNA expression of visfatin and lipocalin‐2 in peripheral blood mononuclear cells from patients with pulmonary tuberculosis
Open Access
- 18 July 2020
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 34 (11) , e23476
Abstract
Background: In this study, we aimed to assess mRNA expressions of visfatin and lipocalin‐2 in peripheral blood mononuclear cells (PBMCs) from patients with pulmonary tuberculosis (PTB).Methods: Overall, 79 PTB patients and 71 healthy controls were enrolled. In PBMCs, mRNA expressions of visfatin and lipocalin‐2 were detected using real‐time quantitative polymerase chain reaction (qRT‐PCR), and the diagnostic value of these adipokine mRNAs in PTB patients was calculated through receiver operating characteristic (ROC) analysis.Results: In PBMCs from PTB patients, the visfatin mRNA level was significantly higher than in healthy controls (P < .001), with no significant association between the lipocalin‐2 mRNA level and PTB patients (P = .933). In PTB patients, lipocalin‐2 mRNA expression positively correlated with the erythrocyte sedimentation rate (ESR) (P = .010). However, the visfatin mRNA level was not associated with any major clinical and laboratory parameter in PTB patients. The ROC curve demonstrated that visfatin could help distinguish PTB patients from healthy controls, with an optimal cutoff value of 0.645 and a corresponding sensitivity of 79.7%.Conclusions: The altered visfatin mRNA expression indicated that this adipokine might play a role in PTB and could be an auxiliary biomarker for PTB diagnosis.Keywords
Funding Information
- Natural Science Foundation of Anhui Province (1908085QH368)
This publication has 31 references indexed in Scilit:
- Ethnic Variation in Inflammatory Profile in TuberculosisPLOS Pathogens, 2013
- Whole Genome Sequencing versus Traditional Genotyping for Investigation of a Mycobacterium tuberculosis Outbreak: A Longitudinal Molecular Epidemiological StudyPLOS Medicine, 2013
- Lipocalin 2 Regulates Inflammation during Pulmonary Mycobacterial InfectionsPLOS ONE, 2012
- Circulating Levels of Adiponectin, Leptin, Fetuin-A and Retinol-Binding Protein in Patients with Tuberculosis: Markers of Metabolism and InflammationPLOS ONE, 2012
- Treatment end point determinants for pulmonary tuberculosis: Human resistin as a surrogate biomarkerTuberculosis, 2011
- Siderocalin inhibits the intracellular replication ofMycobacterium tuberculosisin macrophagesFEMS Immunology & Medical Microbiology, 2010
- Neutrophil-mediated innate immune resistance to mycobacteriaJournal of Clinical Investigation, 2007
- Siderocalin (Lcn 2) Also Binds Carboxymycobactins, Potentially Defending against Mycobacterial Infections through Iron SequestrationStructure, 2005
- Decreased Plasma Leptin Concentrations in Tuberculosis Patients Are Associated with Wasting and InflammationThe Journal of Clinical Endocrinology & Metabolism, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001